Jul 10, 2026
17 MIN READ

Does Taking Mounjaro Cause Hair Loss? What You Need to Know

Hair shedding during tirzepatide therapy concerns many patients, but research shows it's often temporary and tied to rapid weight loss, not the medication itself. PlexusDx explains the science and what you can do.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jul 10, 2026
17 MIN READ

does taking mounjaro cause hair loss? what you need to know — PlexusDx GLP-1 education

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has helped thousands lose weight and improve metabolic health. However, some users report increased hair shedding within weeks or months of starting treatment. Understanding whether tirzepatide directly causes hair loss—or whether weight loss itself triggers temporary shedding—helps you make an informed decision about your therapy.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Understanding Tirzepatide and Hair Loss Reports

Tirzepatide works by slowing stomach emptying and signaling fullness to the brain, leading to rapid calorie reduction and weight loss. Clinical trials of tirzepatide showed weight loss of 15–22% over 68 weeks in adults with obesity. During this period, some participants reported hair shedding, though it was not formally tracked as a primary adverse event in most studies. The occurrence of hair loss during tirzepatide therapy has led patients and clinicians to ask whether the medication itself causes alopecia or whether the underlying weight loss triggers temporary hair cycling.

Hair loss during weight loss periods is medically termed telogen effluvium. This condition occurs when a large number of hair follicles simultaneously shift from the growth phase into the shedding phase. The shift is typically triggered by metabolic stress—such as rapid weight loss, calorie restriction, or nutritional deficiency—rather than by a specific drug compound. Because tirzepatide produces rapid weight loss (often 1–2 pounds per week in the first months), telogen effluvium becomes more likely during early treatment.

Why Rapid Weight Loss Can Trigger Hair Shedding

Hair growth depends on stable supplies of protein, iron, zinc, and B vitamins. When you lose weight quickly, your body shifts into a catabolic state—breaking down tissue and redirecting nutrients to vital organs. Hair follicles, being non-essential for immediate survival, receive lower nutrient priority. This metabolic shift signals resting hair follicles to enter the shedding phase, typically 2–3 months after the weight loss begins. The shedding may appear sudden even though the trigger occurred weeks earlier.

Studies on bariatric surgery patients, who lose weight even faster than tirzepatide users, show that 16–40% experience temporary hair loss within 3–6 months. Most regain full hair density within 6–12 months after weight stabilizes and nutrition normalizes. Because tirzepatide-induced weight loss is generally slower and more gradual than surgical weight loss, hair shedding rates tend to be lower—though individual variation is common.

Tirzepatide Injections: Clinical Evidence on Hair Safety

The Phase 3 SURMOUNT trials, which tested tirzepatide injections in over 2,500 adults with obesity, reported hair loss in fewer than 2% of participants as a treatment-related adverse event. This low rate suggests that tirzepatide itself does not directly damage hair follicles or disrupt the hair growth cycle. Instead, the observed shedding appears tied to the rate and magnitude of weight loss rather than the medication's pharmacology.

PlexusDx offers compounded tirzepatide injections from licensed 503A pharmacies, starting at $289 per month. Because dosing is individualized, your prescriber can adjust your tirzepatide dose to achieve meaningful weight loss while minimizing metabolic stress—potentially reducing the risk of telogen effluvium. Slower, steady weight loss of 0.5–1.5 pounds per week is associated with lower hair shedding rates than rapid losses exceeding 2 pounds weekly.

Preventing and Managing Hair Loss During Tirzepatide Therapy

Adequate nutrition is the strongest defense against weight-loss-related hair shedding. Aim for 1.2–1.6 grams of protein per kilogram of body weight daily, as tirzepatide may reduce appetite for protein-rich foods. Supplement iron (ferritin target: 50–100 ng/mL), zinc (15–30 mg daily), and B vitamins, especially biotin (2.5 mg daily) and B12. A registered dietitian can personalize your nutrition plan to support hair health while on tirzepatide.

If hair shedding occurs, it typically peaks 3–4 months into therapy and resolves within 6–12 months. Resist the urge to wash your hair excessively, use gentle shampoos without sulfates, and avoid tight hairstyles. Minoxidil (Rogaine) can accelerate regrowth if applied topically during the shedding phase, though evidence is stronger for genetic androgenetic alopecia than for telogen effluvium. Contact your PlexusDx prescriber if shedding is severe or persists beyond 6 months—it may signal nutritional deficiency or an unrelated scalp condition.

Personalized Tirzepatide Therapy and Genetic Insights

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which analyzes 14 metabolic pathways and 150+ genetic insights related to peptide therapy response. While the test does not predict hair loss directly, it identifies genetic variants—such as FTO rs9939609 and MC4R rs17782313—that influence your weight loss rate and metabolic response to tirzepatide. Faster responders may benefit from a gentler dosing schedule to protect hair health.

Understanding your genetic peptide profile helps your PlexusDx prescriber optimize your tirzepatide dose for sustainable, metabolically gentle weight loss. This personalized approach reduces the likelihood of the extreme calorie deficit and rapid weight loss that trigger telogen effluvium. Whether you choose compounded tirzepatide injections (starting at $289/mo (or $249/mo on the 6-month plan)) or oral tirzepatide (starting at $349/mo (or $279/mo on the 6-month plan)), PlexusDx serves all 50 states without insurance requirements, making genetic-guided precision therapy accessible.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does tirzepatide directly cause hair loss, or is it the weight loss itself?

Clinical data suggests tirzepatide does not directly damage hair follicles. Hair shedding is primarily linked to the rapid weight loss and metabolic stress tirzepatide produces, a condition called telogen effluvium. Most shedding is temporary and resolves once weight stabilizes and nutrition improves.

How common is hair loss among tirzepatide users?

Hair loss was reported in fewer than 2% of SURMOUNT trial participants as a treatment-related adverse event. However, patient reports online suggest higher rates of shedding (10–15%), likely because temporary shedding is not always reported to prescribers. The variation depends on weight loss speed, baseline nutrition, and individual genetics.

How long does tirzepatide-related hair shedding last?

Telogen effluvium typically peaks 3–4 months after rapid weight loss begins and resolves within 6–12 months in most cases. Hair regrowth accelerates once weight stabilizes and nutritional status normalizes. If shedding persists beyond 12 months, consult your prescriber to rule out other causes.

Can I prevent hair loss while taking tirzepatide?

Yes. Ensure adequate protein (1.2–1.6 g/kg/day), iron, zinc, and B vitamins, especially biotin and B12. Slower weight loss (0.5–1.5 lbs/week) reduces shedding risk compared to rapid losses. Work with a registered dietitian and your PlexusDx prescriber to optimize your dosing schedule and nutrition plan.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The test does not directly predict hair loss, but it identifies genetic variants affecting weight loss rate and metabolic response to tirzepatide. Patients with variants like FTO rs9939609 may lose weight faster and benefit from a gentler tirzepatide dose to minimize metabolic stress and protect hair health. The test costs $99 after your first month of treatment.

Is hair loss a reason to stop tirzepatide therapy?

No. Hair loss from tirzepatide is almost always temporary and self-resolving. Stopping therapy may reverse weight loss progress without stopping shedding. Instead, work with your PlexusDx prescriber to adjust your dose, improve nutrition, and manage the shedding phase. Most patients report full hair recovery within 6–12 months.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves